Waldencast Acquisition Corp Net Assets
Waldencast Acquisition Corp net assets. Based on the latest financial reports, Waldencast Acquisition Corp (WALDW) has net assets worth $500.10 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($816.20 Million) and total liabilities ($316.10 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Waldencast Acquisition Corp net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $500.10 Million |
| % of Total Assets | 61.27% |
| Annual Growth Rate | N/A |
| 5-Year Change | 1174.49% |
| 10-Year Change | N/A |
| Growth Volatility | 845.31 |
Net Assets of Waldencast Acquisition Corp (2020–2025)
Net assets of Waldencast Acquisition Corp from 2020 to 2025. This chart illustrates how Waldencast Acquisition Corp's net assets have evolved over time, based on quarterly financial data. See Waldencast Acquisition Corp (WALDW) net asset quality to measure how much of total assets are equity-financed.
Annual Net Assets for Waldencast Acquisition Corp (2020–2025)
The table below shows the annual net assets of Waldencast Acquisition Corp from 2020 to 2025. For live market cap and overall valuation, see market cap of Waldencast Acquisition Corp.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $500.10 Million | -31.49% |
| 2024-12-31 | $729.94 Million | -5.11% |
| 2023-12-31 | $769.27 Million | -3.83% |
| 2022-12-31 | $799.90 Million | +1938.53% |
| 2021-12-31 | $39.24 Million | +358414.31% |
| 2020-12-31 | $-10.95K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Waldencast Acquisition Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 51894204900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Waldencast Acquisition Corp Net Assets Breakdown (December 2025)
Waldencast Acquisition Corp net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $13.00K | 0.00% |
| Other Comprehensive Income | $-378.00K | -0.08% |
| Other Components | $981.20 Million | 212.44% |
| Total Equity | $461.88 Million | 100.00% |
Waldencast Acquisition Corp Competitors by Market Cap
The table below lists competitors of Waldencast Acquisition Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Aquis Exchange PLC
LSE:AQX
|
$10.66 |
|
Lexaria Bioscience Corp
NASDAQ:LEXXW
|
$11.90 |
|
Jasmine International Public Company Limited
F:JASN
|
$16.05 |
|
Clene Inc
NASDAQ:CLNNW
|
$16.72 |
|
BriaCell Therapeutics Corp
NASDAQ:BCTXW
|
$8.51 |
|
Ucommune International Ltd
NASDAQ:UKOMW
|
$6.97 |
|
immatics biotechnologies GmbH
NASDAQ:IMTXW
|
$5.77 |
|
Neovacs S.A.
PA:ALNEV
|
$5.06 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Waldencast Acquisition Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 662,319,000 to 461,879,000, a change of -200,440,000 (-30.3%).
- Net loss of 229,749,000 reduced equity.
- Other comprehensive income decreased equity by 629,000.
- Other factors increased equity by 29,938,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-229.75 Million | -49.74% |
| Other Comprehensive Income | $-629.00K | -0.14% |
| Other Changes | $29.94 Million | +6.48% |
| Total Change | $- | -30.26% |
Book Value vs Market Value Analysis
This analysis compares Waldencast Acquisition Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $0.90 | $0.00 | x |
| 2022-12-31 | $7.44 | $0.00 | x |
| 2023-12-31 | $6.17 | $0.00 | x |
| 2024-12-31 | $6.06 | $0.00 | x |
| 2025-12-31 | $4.05 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Waldencast Acquisition Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -49.74%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -84.44%
- • Asset Turnover: 0.33x
- • Equity Multiplier: 1.77x
- Recent ROE (-49.74%) is below the historical average (-24.09%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | -2.51% | 566.14x | 0.00x | $-2.37 Million |
| 2021 | -49.89% | -13.74% | 0.77x | 4.70x | $-23.50 Million |
| 2023 | -14.41% | -41.25% | 0.21x | 1.67x | $-152.44 Million |
| 2024 | -6.41% | -15.50% | 0.28x | 1.47x | $-108.67 Million |
| 2025 | -49.74% | -84.44% | 0.33x | 1.77x | $-275.94 Million |
Industry Comparison
This section compares Waldencast Acquisition Corp's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Waldencast Acquisition Corp (WALDW) | $500.10 Million | 0.00% | 0.63x | $9.79 |
| Advent Technologies Holdings Inc (ADNWW) | $13.45 Million | -530.91% | 1.58x | $28.31 |
| AIxCrypto Holdings, Inc. (AIXC) | $-148.12K | 0.00% | 0.00x | $21.32 Million |
| AmpliTech Group Inc (AMPGW) | $-220.24K | 0.00% | 0.00x | $716.18 |
| Arko Corp (ARKOW) | $224.17 Million | 4.89% | 3.81x | $25.17 |
| Aris Mining Corporation (ARMN) | $245.68 Million | -1.38% | 0.83x | $3.93 Billion |
| Aberdeen Standard Global Infrastructure Income Fund (ASGI) | $482.92 Million | 1.71% | 0.01x | $472.62 Million |
| Atlas Corp (ATCOL) | $5.20 Billion | 12.93% | 2.30x | $244.80K |
| Auddia Inc (AUUDW) | $-9.09 Million | 0.00% | 0.00x | $372.87 |
| BriaCell Therapeutics Corp (BCTXW) | $9.33 Million | -3.95% | 0.01x | $8.51 |
| Blaize Holdings, Inc. Warrants (BZAIW) | $-70.54 Million | 0.00% | 0.00x | $330.55K |
About Waldencast Acquisition Corp
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; co… Read more